India-focused private investment firm WestBridge Capital and U.S.-based private equity firm TA Associates have together invested US$44 million in Dr. Lal PathLabs, an Indian pathology and diagnostics company. WestBridge invested US$35 million from its evergreen fund WestBridge Crossover Fund, with TA Associates contributing US$9 million. Under the terms of the transaction, part of the stake acquired by the two firms came from another fund managed by WestBridge, which invested in Dr. Lal Pathlabs in 2005.